Management of asthma in childhood : Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
(2021) In BMJ Open 11(7).- Abstract
Introduction Clinical recommendations for childhood asthma are often based on data extrapolated from studies conducted in adults, despite significant differences in mechanisms and response to treatments. The Paediatric Asthma in Real Life (PeARL) Think Tank aspires to develop recommendations based on the best available evidence from studies in children. An overview of systematic reviews (SRs) on paediatric asthma maintenance management and an SR of treatments for acute asthma attacks in children, requiring an emergency presentation with/without hospital admission will be conducted. Methods and analysis Standard methodology recommended by Cochrane will be followed. Maintenance pharmacotherapy of childhood asthma will be evaluated in an... (More)
Introduction Clinical recommendations for childhood asthma are often based on data extrapolated from studies conducted in adults, despite significant differences in mechanisms and response to treatments. The Paediatric Asthma in Real Life (PeARL) Think Tank aspires to develop recommendations based on the best available evidence from studies in children. An overview of systematic reviews (SRs) on paediatric asthma maintenance management and an SR of treatments for acute asthma attacks in children, requiring an emergency presentation with/without hospital admission will be conducted. Methods and analysis Standard methodology recommended by Cochrane will be followed. Maintenance pharmacotherapy of childhood asthma will be evaluated in an overview of SRs published after 2005 and including clinical trials or real-life studies. For evaluating pharmacotherapy of acute asthma attacks leading to an emergency presentation with/without hospital admission, we opted to conduct de novo synthesis in the absence of adequate up-to-date published SRs. For the SR of acute asthma pharmacotherapy, we will consider eligible SRs, clinical trials or real-life studies without time restrictions. Our evidence updates will be based on broad searches of Pubmed/Medline and the Cochrane Library. We will use A MeaSurement Tool to Assess systematic Reviews, V.2, Cochrane risk of bias 2 and REal Life EVidence AssessmeNt Tool to evaluate the methodological quality of SRs, controlled clinical trials and real-life studies, respectively. Next, we will further assess interventions for acute severe asthma attacks with positive clinical results in meta-analyses. We will include both controlled clinical trials and observational studies and will assess their quality using the previously mentioned tools. We will employ random effect models for conducting meta-analyses, and Grading of Recommendations Assessment, Development and Evaluation methodology to assess certainty in the body of evidence. Ethics and dissemination Ethics approval is not required for SRs. Our findings will be published in peer reviewed journals and will inform clinical recommendations being developed by the PeARL Think Tank. PROSPERO registration numbers CRD42020132990, CRD42020171624.
(Less)
- author
- publishing date
- 2021-07-02
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- asthma, paediatric thoracic medicine, paediatrics, thoracic medicine
- in
- BMJ Open
- volume
- 11
- issue
- 7
- article number
- e048338
- publisher
- BMJ Publishing Group
- external identifiers
-
- scopus:85109134715
- pmid:34215609
- ISSN
- 2044-6055
- DOI
- 10.1136/bmjopen-2020-048338
- language
- English
- LU publication?
- no
- id
- 10afbd07-6d8e-414c-86f2-e895e43bcf4e
- date added to LUP
- 2021-08-23 10:36:57
- date last changed
- 2024-04-20 09:58:53
@article{10afbd07-6d8e-414c-86f2-e895e43bcf4e,
abstract = {{<p>Introduction Clinical recommendations for childhood asthma are often based on data extrapolated from studies conducted in adults, despite significant differences in mechanisms and response to treatments. The Paediatric Asthma in Real Life (PeARL) Think Tank aspires to develop recommendations based on the best available evidence from studies in children. An overview of systematic reviews (SRs) on paediatric asthma maintenance management and an SR of treatments for acute asthma attacks in children, requiring an emergency presentation with/without hospital admission will be conducted. Methods and analysis Standard methodology recommended by Cochrane will be followed. Maintenance pharmacotherapy of childhood asthma will be evaluated in an overview of SRs published after 2005 and including clinical trials or real-life studies. For evaluating pharmacotherapy of acute asthma attacks leading to an emergency presentation with/without hospital admission, we opted to conduct de novo synthesis in the absence of adequate up-to-date published SRs. For the SR of acute asthma pharmacotherapy, we will consider eligible SRs, clinical trials or real-life studies without time restrictions. Our evidence updates will be based on broad searches of Pubmed/Medline and the Cochrane Library. We will use A MeaSurement Tool to Assess systematic Reviews, V.2, Cochrane risk of bias 2 and REal Life EVidence AssessmeNt Tool to evaluate the methodological quality of SRs, controlled clinical trials and real-life studies, respectively. Next, we will further assess interventions for acute severe asthma attacks with positive clinical results in meta-analyses. We will include both controlled clinical trials and observational studies and will assess their quality using the previously mentioned tools. We will employ random effect models for conducting meta-analyses, and Grading of Recommendations Assessment, Development and Evaluation methodology to assess certainty in the body of evidence. Ethics and dissemination Ethics approval is not required for SRs. Our findings will be published in peer reviewed journals and will inform clinical recommendations being developed by the PeARL Think Tank. PROSPERO registration numbers CRD42020132990, CRD42020171624. </p>}},
author = {{Mathioudakis, Alexander G. and Miligkos, Michael and Boccabella, Cristina and Alimani, Gioulinta S. and Custovic, Adnan and Deschildre, A. and Ducharme, Francine Monique and Kalayci, Omer and Murray, Clare and Garcia, Antonio Nieto and Phipatanakul, Wanda and Price, David and Sheikh, Aziz and Agache, Ioana Octavia and Bacharier, Leonard and Beloukas, Apostolos and Bentley, Andrew and Bonini, Matteo and Castro-Rodriguez, Jose A. and De Carlo, Giuseppe and Craig, Timothy and Diamant, Zuzana and Feleszko, Wojciech and Felton, Tim and Gern, James E. and Grigg, Jonathan and Hedlin, Gunilla and Hossny, Elham M. and Ierodiakonou, Despo and Jartti, Tuomas and Kaplan, Alan and Lemanske, Robert F. and Le Souëf, Peter N. and Mäkelä, Mika J. and Mathioudakis, Georgios A. and Matricardi, Paolo and Mitrogiorgou, Marina and Morais-Almeida, Mario and Nagaraju, Karthik and Papageorgiou, Effie and Pité, Helena and Pitrez, Paulo M.C. and Pohunek, Petr and Roberts, Graham and Tsiligianni, Ioanna and Turner, Stephen and Vijverberg, Susanne and Winders, Tonya A. and Wong, Gary W.K. and Xepapadaki, Paraskevi and Zar, Heather J and Papadopoulos, Nikolaos G}},
issn = {{2044-6055}},
keywords = {{asthma; paediatric thoracic medicine; paediatrics; thoracic medicine}},
language = {{eng}},
month = {{07}},
number = {{7}},
publisher = {{BMJ Publishing Group}},
series = {{BMJ Open}},
title = {{Management of asthma in childhood : Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank}},
url = {{http://dx.doi.org/10.1136/bmjopen-2020-048338}},
doi = {{10.1136/bmjopen-2020-048338}},
volume = {{11}},
year = {{2021}},
}